
Richard Ehlers MD
Breast, Melanoma, Surgical Oncology (Other than Breast)
Executive Medical Director and Associate Vice President, MD Anderson Houston Area Locations
Join to View Full Profile
2280 Gulf Freeway SouthLeague City, TX 77573
Phone+1 713-834-6624
Fax+1 281-332-9610
Dr. Ehlers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2002 - 2004
- University of Texas Medical Branch HospitalsResidency, Surgery, 1995 - 2002
- University of Texas Medical Branch School of MedicineClass of 1995
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- TX State Medical License 2001 - 2026
- WA State Medical License 2023 - 2026
- AL State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- American Board of Surgery Surgery
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients with Breast Cancer Undergoing Breast Surgery Start of enrollment: 2019 May 21
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 6 citationsPremastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial.Mark V Schaverien, Puneet Singh, Benjamin D Smith, Wei Qiao, Catherine L Akay
JAMA Network Open. 2024-04-01 - MD Anderson's 10-year experience with regional surgical oncology in the Houston area locations.Richard A Ehlers, Peter P W Pisters, Nancy D Perrier
Surgery. 2022-04-01 - 4 citationsAuthor Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.Rodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, Michael A Davies, Merrick I Ross
Nature Medicine. 2018-12-01
Journal Articles
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaScott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
- Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaRichard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: